Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
UBS
Chubb
Mallinckrodt
Queensland Health
Moodys
Healthtrust
Fuji
McKesson

Generated: May 21, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,282,233

« Back to Dashboard

Summary for Patent: 4,282,233
Title: Antihistaminic 11-(4-piperidylidene)-5H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridines
Abstract:11-(4-Piperidylidene)-5H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridines and their 5,6-dihydro derivatives are disclosed. The compounds are useful as antihistamines with little or no sedative effects.
Inventor(s): Vilani; Frank J. (West Caldwell, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:06/160,795
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,282,233
Patent Claims: 1. A compound of the formula ##STR2## wherein the dotted line represents an optional double bond; X is hydrogen or halo; and

wherein Y is --COOR or SO.sub.2 R; with the proviso that when Y is --COOR, R is C.sub.1 to C.sub.12 alkyl, substituted C.sub.1 to C.sub.12 alkyl, phenyl, substituted phenyl, C.sub.7 to C.sub.12 phenylalkyl, C.sub.7 to C.sub.12 phenylalkyl wherein the phenyl moiety is substituted or R is -2,-3, or -4 piperidyl or N-substituted piperidyl wherein the substituents on said substituted C.sub.1 to C.sub.12 alkyl are selected from amino or substituted amino and the substituents on said substituted amino are selected from C.sub.1 to C.sub.6 alkyl, the substituents on said substituted phenyl and on said substituted phenyl moiety of the C.sub.7 to C.sub.12 phenylalkyl are selected from C.sub.1 to C.sub.6 alkyl and halo, and the substituent on said N-substituted piperidyl is C.sub.1 to C.sub.4 alkyl; and with the proviso that when Y is SO.sub.2 R, R is C.sub.1 to C.sub.12 alkyl, phenyl, substituted phenyl, C.sub.7 to C.sub.12 phenylalkyl, C.sub.7 to C.sub.12 phenylalkyl wherein the phenyl moiety is substituted, wherein the substituents on said substituted phenyl and said substituted phenyl moiety of the C.sub.7 to C.sub.12 phenylalkyl are selected from C.sub.1 to C.sub.6 alkyl and halo.

2. A compound according to claim 1, wherein Y is --COOR, wherein R is as defined in claim 1, said compound having a single bond between the 5- and 6-carbons.

3. A compound according to claim 1, wherein Y is --SO.sub.2 R, wherein R is as defined in claim 1, said compound having a single bond between the 5- and 6-carbons.

4. A compound according to claim 2, wherein X is hydrogen, said compound having a single bond between the 5- and 6-carbons.

5. A compound according to claim 2, wherein X is 8-chloro, said compound having a single bond between the 5- and 6-carbons.

6. A compound according to claim 3, wherein X is hydrogen, said compound having a single bond between the 5- and 6-carbons.

7. 11-(N-carboethoxy-4-piperidylidene)-8-chloro-6,1 1-dihydro-5H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridine.

8. 11-(N-methanesulfonyl-4-piperidylidene)-6,11-dihyd ro-5H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridine.

9. 11-(N-carboethoxy-4-piperidylidene)-6,11-di hydro-5H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridine.

10. 11-(N-carbomethoxy-4-piperidylidene)-6,11-dih ydro-5H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridine.

11. 11-(N-carbophenoxy-4-piperidylidene)-6,11-di hydro-5H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridine.

12. An antihistaminic pharmaceutical composition comprising an effective amount of a compound as claimed in any one of claims 1-10 and a pharmaceutically acceptable carrier.

13. A method of effecting an anti-allergic response in an animal comprising administering to the animal an effective amount of a compound as claimed in any one of claims 1 to 11.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Medtronic
Cantor Fitzgerald
Harvard Business School
US Department of Justice
Queensland Health
Deloitte
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.